Roth David
- SEC CIK
- 0001599014
No open-market purchases or sales filed in the past year.
Current role at each company
- SYRS Syros Pharmaceuticals, Inc.Chief Medical Officeras of Nov 20, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Roth David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 20, 2024 (view filing)5:00 PM ET | Nov 18 | 2 days | Roth DavidChief Medical Officer | SSale | −12.1K | $0.1969 | −$2.38K | −100.0%0 after | |
| Apr 5, 2024 (view filing) | Apr 3 | 2 days | Roth DavidChief Medical Officer | SSale | −10.5K | $4.95 | −$51.7K | −100.0%0 after | 10b5-1 |
| Apr 2, 2024 (view filing) | Apr 2 | Same day | Roth DavidChief Medical Officer | SSale | −150 | $4.98 | −$747 | −1.4%10.5K after | 10b5-1 |
| Dec 14, 2023 (view filing) | Dec 12 | 2 days | Roth DavidChief Medical Officer | SSale | −6.29K | $4.95 | −$31.1K | −100.0%0 after | 10b5-1 |
| Dec 8, 2023 (view filing) | Dec 6 | 2 days | Roth DavidChief Medical Officer | SSale | −6.29K | $3.95 | −$24.8K | −50.0%6.29K after | 10b5-1 |
| Aug 2, 2023 (view filing) | Jul 31 | 2 days | Roth DavidChief Medical Officer | SSale | −7.35K | $3.95 | −$29.0K | −100.0%0 after | 10b5-1 |